Companies: 10,795·Total market cap: $144.5T
Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.

VVOSNASDAQHealthcare● Active
$0.87
+$0.01(+0.64%)
Market Cap$5123882
P/E Ratio—
52W High$7.95
52W Low$0.545
Overview
Stock ranking:Medical - Devices·Healthcare·View All Market Cap Rankings →

Vivos Therapeutics, Inc. (VVOS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · VVOS · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.30vvos eps ttm · vvos earnings per shareEarnings history
PE Ratio (TTM)—vvos pe ratio ttm · vvos price to earningsPE Ratio deep dive
Revenue (TTM)$19.6Mvvos revenue ttm · vvos annual revenueFull revenue history
Dividend YieldNo Dividenddoes vvos pay dividends · vvos dividend yieldDividend history
Shares Outstanding10.3Mvvos shares outstanding · vvos floatShares outstanding history
Next EarningsAug 18, 2026Est.vvos earnings date · vvos next earningsEarnings history

Explore Vivos Therapeutics, Inc. Data

vvos stock data · financials
Market Cap$5.1Mvvos market cap · vvos valuation
Analyst Forecast$2 · Buy
DividendsNo Dividenddoes vivos therapeutics, inc. pay dividends · vvos dividend yield
Revenue$17.4M+16.05%vivos therapeutics, inc. annual revenue · vvos revenue
EarningsEPS $-2.06+7.21%vvos earnings · vvos eps
PE Ratio—vvos pe ratio · vvos price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$17.4M▲ +16.05% YoY
202320242025
vivos therapeutics, inc. revenue · vvos revenue 2025
FY 2025Net Income-$21.2M▼ 90.64% YoY
202320242025
vivos therapeutics, inc. net income · vvos profit 2025
FY 2025EPS$-2.06▲ +7.21% YoY
202320242025
vvos eps · vivos therapeutics, inc. earnings per share 2025
TTM:Revenue: $19.6MNet Income: -$25.1MEPS: $-2.30View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis vvos a buy · vvos analyst rating
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$1.75Low
$0.87Current
$2.13Avg Target144.83% upside
$2.50High
vvos price target · vvos 12 month forecast

Total: 5 · Buy rate: 100.0%

The VVOS analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $2.13, representing +144.83% upside from the current price of $0.87.

Stock Performance

Full History
1D+0.64%
1W+30.49%
1M+30.87%
3M-34.59%
YTD-57.14%
1Y-59.35%
5Y-99.36%

About Vivos Therapeutics, Inc.

CEOR. Kirk Huntsman
IPO DateDec 11, 2020
Employees109
CountryUS
Websitevivos.com

Vivos Therapeutics, Inc. is a medical technology enterprise dedicated to developing and commercializing advanced treatment solutions for adults facing conditions like dentofacial abnormalities, obstru…

Medical - DevicesHealthcareNASDAQUS

what is vivos therapeutics, inc. · vvos stock overview · vivos therapeutics, inc. company profile · who is vivos therapeutics, inc. ceo · vvos NASDAQ · vivos therapeutics, inc. headquarters · vivos therapeutics, inc. business segments

About Stock Overview & Key Data

Vivos Therapeutics, Inc. (VVOS) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Dec 11, 2020. As of the latest trading session, VVOS stock price is $0.87, with a market capitalization of $5.1M. The stock has returned -59.35% over the past 12 months and -57.14% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Vivos Therapeutics, Inc. stock is Buy, with an average 12-month price target of $2.13. In fiscal year 2025, Vivos Therapeutics, Inc. reported revenue of $17.4M and net income of -$21.2M. For detailed data — including Vivos Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Vivos Therapeutics, Inc. (VVOS) stock price is $0.87. The stock is traded on NASDAQ under the ticker symbol VVOS. The 52-week range is $0.55 – $7.95.

VVOS stock priceVVOS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice